why choose us

First received: December 07, 2023

Clinical Trial: Abiraterone and Prednisone or Darolutamide for the Treatment of Advanced Prostate Cancer

Study Status: Completed

Recruit Status: RECRUITING

Condition: Advanced Prostate Adenocarcinoma

Study Type: INTERVENTIONAL


Official Title: A Pragmatic Phase II Study Evaluating Tolerability in Prostate Cancer Patients Treated With Abiraterone + Prednisone or Darolutamide

Brief Summary: This phase II trial compares the effects, good and/or bad of abiraterone and prednisone or darolutamide alone in treating patients with prostate cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced).Androgens (male hormones) can cause the growth of prostate tumor cells.Abiraterone acetate lowers the amount of androgens made by the body.This may help stop the growth of prostate tumor cells that need androgen to grow.Darolutamide blocks…

Read more